Learning that she has what used to be called premature menopause can devastate a woman in her 20s or 30s. Diagnose this mysterious condition without delay, deliver the bad news in person, and provide sensitiveanswers to four basic questions.
Spontaneous POF-the development of amenorrhea, sex hormone deficiency, and elevated serum gonadotropin levels before age 40-affects about 1% of women.1 For the women with this disordered menstrual pattern whom we've seen at the National Institutes of Health (NIH) Clinical Center, the median age of onset is 25 years.2 The term "spontaneous" means that the ovarian failure wasn't induced by chemotherapy, radiation therapy, or surgery. In the majority of cases the disturbance in menstrual regularity is a secondary development, as most of these patients have experienced normal puberty with menarche and the development of secondary sexual characteristics.2,3
Patients often complain about how long it took them to get a diagnosis of POF. Certainly, the first clinical challenge is to diagnose this disorder early on (Table 1).
Do the right tests. Readily available commercial assays make it possible to quantify circulating steroid and protein hormone levels, enabling us to differentiate patients with amenorrhea into distinct etiologic categories. In 1990 Rebar and Connolly recommended laboratory evaluation for all women with amenorrhea to identify women with spontaneous POF or other types of amenorrhea.3 Although a complete discussion about the differential diagnosis of secondary amenorrhea is beyond the scope of this review, a careful history and physical examination can lead to an appropriately targeted evaluation.4
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Major congenital malformations not linked to first trimester tetracycline use
November 20th 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Read More
No link found between prenatal cannabis use and childhood developmental delay
November 5th 2024In a recent study, offspring of women with cannabis use in early pregnancy confirmed by self-report or toxicology test were not at an increased risk of childhood early developmental delay up to the age of 5.5 years.
Read More
Prenatal cannabis use not linked to offspring ASD development
November 1st 2024In a recent study, adjustments for maternal characteristics mediated the association between maternal prenatal cannabis use and offspring autism spectrum disorder, indicating no statistically significant increase in risk.
Read More
Importance of reproductive health services for adolescents during the COVID-19 pandemic
October 30th 2024In a recent study, high rates of reproductive health service use were reported among adolescent mothers, indicating the benefits of this model for providing care when other options are unavailable.
Read More